I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 20 studies | 24% ± 8% | |
| endothelial cell | 17 studies | 29% ± 12% | |
| smooth muscle cell | 16 studies | 27% ± 10% | |
| B cell | 15 studies | 24% ± 8% | |
| endothelial cell of lymphatic vessel | 13 studies | 31% ± 9% | |
| astrocyte | 11 studies | 42% ± 14% | |
| natural killer cell | 10 studies | 23% ± 9% | |
| adipocyte | 9 studies | 45% ± 6% | |
| fibroblast | 8 studies | 22% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 20% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 24% ± 7% | |
| memory B cell | 6 studies | 21% ± 6% | |
| naive B cell | 6 studies | 26% ± 10% | |
| abnormal cell | 5 studies | 28% ± 5% | |
| epithelial cell | 5 studies | 44% ± 21% | |
| myofibroblast cell | 5 studies | 22% ± 5% | |
| oligodendrocyte precursor cell | 4 studies | 19% ± 5% | |
| mucosal invariant T cell | 4 studies | 29% ± 9% | |
| connective tissue cell | 4 studies | 27% ± 3% | |
| plasma cell | 4 studies | 27% ± 6% | |
| retinal cone cell | 4 studies | 19% ± 4% | |
| hepatocyte | 4 studies | 60% ± 21% | |
| GABAergic neuron | 4 studies | 28% ± 2% | |
| glutamatergic neuron | 4 studies | 44% ± 12% | |
| neuron | 4 studies | 39% ± 13% | |
| plasmablast | 3 studies | 18% ± 1% | |
| glial cell | 3 studies | 25% ± 8% | |
| precursor B cell | 3 studies | 30% ± 12% | |
| immature B cell | 3 studies | 26% ± 5% | |
| lymphocyte | 3 studies | 19% ± 3% | |
| innate lymphoid cell | 3 studies | 31% ± 18% | |
| endothelial cell of vascular tree | 3 studies | 28% ± 9% | |
| muscle cell | 3 studies | 23% ± 4% | |
| group 3 innate lymphoid cell | 3 studies | 32% ± 17% | |
| Schwann cell | 3 studies | 23% ± 5% | |
| melanocyte | 3 studies | 25% ± 6% | |
| transit amplifying cell | 3 studies | 30% ± 17% |
